Monday, November 28, 2016 12:30:38 AM
The passage of the 21st Century Cures Act will be a HUGE Deal for Breathtec moving into the future > It directly provides for rapid FDA approval of medical devices and big dollar grant money for continuing research. This is a huge deal for Breathtec no matter how one looks at it. Access to HUGE dollars (grants) to push further with innovations for additional products, with less restrictive timeline to market. The American people have spoken loud and clear! They want lawmakers to invest over 10 Billion dollars into Biomedical research. What I find most compelling is Breathtec's global reach with no direct competitors utilizing FAIMS/MS coupled with NA-NOSE technology. Breathtec has stated the facts via Audio, Video, and Print media. But, there will be nay sayers and non believers Until The Tide Comes Rolling In. Penny Stock Land will soon enough be our past, and less volatility will be our future coordinates. We have the experts. We have the technology, and were leading the way.
FAIMS-MS/NA-NOSE
CHARTING UNCHARTED WATERS
/////AMG
Post Script:
ILuvblo2 - "Nice find agm. I have a feeling December will be a huge month for bth."
Amg - Thx. I've been following the 21st Century Cures Act for several months now. From all indications, it's about to be a done deal (keeping fingers Xd). As you noted in a previous post, we have lots of pending news. Passage of the 21st Century Cures Act would be another positive motivator for current and future investors.
Breathtec's targeted market has an unlimited global footprint. Anyone old enough to blow bubbles (Age 2 to 102) will benefit from our medical devices. Who doesn't fall into the category of "Patient" in the developed world in one's lifetime? This is bar none - the opportunity of an investor's lifetime!
Making O's (mOnEy) with E's
Breathtec Biomedical Inc.
Location of Clinical Trials: Additional Info
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM